Ophthalmic complications following megavoltage irradiation of the nasal and paranasal cavities in dogs.
Megavoltage x-radiation was used to treat orbital nasal, and paranasal cavity malignant neoplasia in 29 dogs. In each instance, the globe and adnexal tissues were within the treatment portals (entry and/or exit). Doses administered to tumors ranged from 3,680 to 5,000 cGy. Ocular reactions after irradiation were classified as mild in 5 of 29 cases (17.2%) and severe in 17 of 29 cases (58.6%). No ocular complications were noticed in 7 of 29 cases (24.1%). Complications frequently noticed included severe keratitis (41%), mild conjunctivitis (34%), severe conjunctivitis (28%), cataract (28%), and keratoconjunctivitis sicca (24%). Ocular complications that developed were not life threatening, but posed a threat to visual function and patient quality of life. Treatment for the complications included control of bacterial infection, reduction of tissue inflammation, and ocular surface protection when tear film deficiencies were noticed. Mild complications represented acute effects of irradiation, and typically resolved. Severe complications developed both acutely and as late irradiation effects. Those attributed to late irradiation effects were more vision threatening and altered the quality of life more than did the early effects.
D000818:Animals; D004283:Dog Diseases / Q000209:etiology / Q000532:radiotherapy*; D004285:Dogs; D005128:Eye Diseases / Q000209:etiology / Q000662:veterinary*; D006258:Head and Neck Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000662:veterinary*; D009669:Nose Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000662:veterinary; D009918:Orbital Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000662:veterinary; D010255:Paranasal Sinus Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000662:veterinary; D011882:Radiotherapy, High-Energy / Q000009:adverse effects / Q000662:veterinary*